Page last updated: 2024-08-22

pimozide and Hepatocellular Carcinoma

pimozide has been researched along with Hepatocellular Carcinoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, N; Chen, JJ; Ji, K; Zhang, LN; Zhang, Z1
Cai, N; Chen, GZ; Chen, JJ; Du, C; Jia, CC; Liu, W; Long, ZJ; Qiu, DB; Yang, Y; Zhang, Q1
Budhu, AS; Fako, V; Henrich, CJ; Ransom, T; Wang, XW; Yu, Z1

Other Studies

3 other study(ies) available for pimozide and Hepatocellular Carcinoma

ArticleYear
Antipsychotic agent pimozide promotes reversible proliferative suppression by inducing cellular quiescence in liver cancer.
    Oncology reports, 2019, Volume: 42, Issue:3

    Topics: Antipsychotic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Humans; Liver Neoplasms; Pimozide; Reactive Oxygen Species; Resting Phase, Cell Cycle; Signal Transduction; Tumor Cells, Cultured

2019
The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma.
    Oncotarget, 2017, Mar-14, Volume: 8, Issue:11

    Topics: Animals; Antineoplastic Agents; Antipsychotic Agents; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Liver Neoplasms; Male; Mice; Mice, Nude; Neoplastic Stem Cells; Pimozide; Real-Time Polymerase Chain Reaction; STAT3 Transcription Factor; Transcriptome; Xenograft Model Antitumor Assays

2017
Inhibition of wnt/β-catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide.
    International journal of biological sciences, 2016, Volume: 12, Issue:7

    Topics: Antipsychotic Agents; Apoptosis; beta Catenin; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Epithelial Cell Adhesion Molecule; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Pimozide; Signal Transduction; Wnt Proteins

2016